BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23454102)

  • 1. Derivation of a chronic reference concentration for decalin.
    Stuchal LD; Weil RE; Roberts SM
    Regul Toxicol Pharmacol; 2013 Jun; 66(1):38-46. PubMed ID: 23454102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using physiologically based pharmacokinetic modeling and benchmark dose methods to derive an occupational exposure limit for N-methylpyrrolidone.
    Poet TS; Schlosser PM; Rodriguez CE; Parod RJ; Rodwell DE; Kirman CR
    Regul Toxicol Pharmacol; 2016 Apr; 76():102-12. PubMed ID: 26776754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha 2u-globulin nephropathy and carcinogenicity following exposure to decalin (decahydronaphthalene) in F344/N rats.
    Dill JA; Lee KM; Renne RA; Miller RA; Fuciarelli AF; Gideon KM; Chan PC; Burka LT; Roycroft JH
    Toxicol Sci; 2003 Apr; 72(2):223-34. PubMed ID: 12660359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of PBPK modeling in support of the derivation of toxicity reference values for 1,1,1-trichloroethane.
    Lu Y; Rieth S; Lohitnavy M; Dennison J; El-Masri H; Barton HA; Bruckner J; Yang RS
    Regul Toxicol Pharmacol; 2008 Mar; 50(2):249-60. PubMed ID: 18226845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single administration toxicokinetic studies of decalin (decahydronaphthalene) in rats and mice.
    Dill JA; Fuciarelli AF; Lee KM; Mellinger KM; Chan PC; Burka LT; Roycroft JH
    Toxicol Sci; 2003 Apr; 72(2):210-22. PubMed ID: 12660358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health assessment of phosgene: approaches for derivation of reference concentration.
    Gift JS; McGaughy R; Singh DV; Sonawane B
    Regul Toxicol Pharmacol; 2008 Jun; 51(1):98-107. PubMed ID: 18440110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation of a chronic reference dose and reference concentration for trimethylbenzenes and C9 aromatic hydrocarbon solvents.
    Firth MJ
    Regul Toxicol Pharmacol; 2008 Dec; 52(3):248-56. PubMed ID: 18809451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of a physiologically based pharmacokinetic model for reference dose and reference concentration estimation for acetone.
    Gentry PR; Covington TR; Clewell HJ; Anderson ME
    J Toxicol Environ Health A; 2003 Dec; 66(23):2209-25. PubMed ID: 14612334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivation of noncancer reference values for acrylonitrile.
    Kirman CR; Sweeney LM; Gargas ML; Strother DE; Collins JJ; Deskin R
    Risk Anal; 2008 Oct; 28(5):1375-94. PubMed ID: 18761732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 90-day vapor inhalation toxicity study of decalin.
    Gaworski CL; Haun CC; MacEwen JD; Vernot EH; Bruner RH; Amster RL; Cowan MJ
    Fundam Appl Toxicol; 1985 Aug; 5(4):785-93. PubMed ID: 4043600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derivation of an occupational exposure limit for an inhalation analgesic methoxyflurane (Penthrox(®)).
    Frangos J; Mikkonen A; Down C
    Regul Toxicol Pharmacol; 2016 Oct; 80():210-25. PubMed ID: 27181451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivation of a bisphenol A oral reference dose (RfD) and drinking-water equivalent concentration.
    Willhite CC; Ball GL; McLellan CJ
    J Toxicol Environ Health B Crit Rev; 2008 Feb; 11(2):69-146. PubMed ID: 18188738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Reference Dose for ethylene glycol based on oxalate crystal-induced renal tubule degeneration as the critical effect.
    Snellings WM; Corley RA; McMartin KE; Kirman CR; Bobst SM
    Regul Toxicol Pharmacol; 2013 Mar; 65(2):229-41. PubMed ID: 23266425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian methods for uncertainty factor application for derivation of reference values.
    Simon TW; Zhu Y; Dourson ML; Beck NB
    Regul Toxicol Pharmacol; 2016 Oct; 80():9-24. PubMed ID: 27211295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human health screening level risk assessments of tertiary-butyl acetate (TBAC): calculated acute and chronic reference concentration (RfC) and Hazard Quotient (HQ) values based on toxicity and exposure scenario evaluations.
    Bus JS; Banton MI; Faber WD; Kirman CR; McGregor DB; Pourreau DB
    Crit Rev Toxicol; 2015 Feb; 45(2):142-71. PubMed ID: 25629921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Final report on the safety assessment of Trichloroethane.
    Int J Toxicol; 2008; 27 Suppl 4():107-38. PubMed ID: 19101834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate.
    Kirman CR; Sweeney LM; Corley R; Gargas ML
    Risk Anal; 2005 Apr; 25(2):271-84. PubMed ID: 15876203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhalation cancer risk assessment of cobalt metal.
    Suh M; Thompson CM; Brorby GP; Mittal L; Proctor DM
    Regul Toxicol Pharmacol; 2016 Aug; 79():74-82. PubMed ID: 27177823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a chronic inhalation reference value for hexamethylenediamine using an exposure model based on the dihydrochloride salt.
    Myers JL; Grant RL
    Inhal Toxicol; 2015; 27(9):440-9. PubMed ID: 26213288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-cancer risk assessment for nickel compounds: issues associated with dose-response modeling of inhalation and oral exposures.
    Haber LT; Allen BC; Kimmel CA
    Toxicol Sci; 1998 Jun; 43(2):213-29. PubMed ID: 9710963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.